Bio Key International INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OQB
BIO-key International reported increased revenues for Q2 2026 driven by license fees, but continued to incur significant operating losses and faces ongoing liquidity challenges.
OQB
BIO-key International reported a significant increase in cash and working capital for Q3 2025, driven by financing activities, despite continued operating losses and a decline in overall revenue.
OQB
BIO-key International, Inc. reported a reduced net loss and increased cash, but continues to face substantial doubt about its ability to continue as a going concern.
OQB
10-Q: BIO-key International Reports Q1 2025 Results: Revenue Declines, Focus Shifts to BIO-key Products
BIO-key International's Q1 2025 revenue decreased due to a shift in sales strategy, but warrant exercises boosted cash reserves.
OQB
Bio-Key International's Q3 2024 results show increased revenue in license fees and hardware sales, but the company continues to face net losses and going concern challenges.
OQB
BIO-key International's Q2 2024 results show a significant revenue decrease compared to the previous year, alongside a new secured promissory note to bolster working capital.
OQB
BIO-key International's Q1 2024 results show a slight decrease in overall revenue, but a significant improvement in gross profit, alongside ongoing efforts to address internal control weaknesses.